Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas

Japanese Journal of Radiology

Volumn 30, Issue 7, 2012, Pages 553-559

  Yamanaka, Takashi ^a   Yamakado, Koichiro ^a   Takaki, Haruyuki ^a   Nakatsuka, Atsuhiro ^a   Shiraki, Katsuya ^a   Hasegawa, Hiroshi ^b   Takei, Yoshiyuki ^a   Takeda, Kan ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Mie Chuo Medical Center   (Japan)

Author keywords

Abdomen; Ablation procedure; Chemoembolization; Liver cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT DURATION;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84866043798     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-012-0087-2     Document Type: Article

References (24)

1. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967.
2. Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology. 2007;72(Suppl 1):98-103.
3. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253-1262.
4. Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001;177:777-782.
5. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, MarchianòA, Fornari F, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119-126.
6. Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 1998;9:101-111.
7. Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol. 2002;13:1225-1232.
8. Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep. 2004;11:105-109.
9. Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, et al. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized control trial. Liver Int. 2004;24:625-629.
10. Takaki H, Yamakado K, Nakatsuka A, Fuke H, Murata K, Shiraki K, et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol. 2007;18:856-861.
11. Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, et al. Early stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology. 2008;247:260-266.
12. Kang SG, Yoon CJ, Jeong SH, Kim JW, Lee SH, Lee KH, et al. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol. 2009;20:1570-1577.
13. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer. 2010;116: 3638-3644.
14. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421-430.
15. Mulier S, Ni Y, Frich L, Burdio F, Denys AL, De Wispelaere JF, et al. Experimental and clinical radiofrequency ablation: proposal for standardized description of coagulation size and geometry. Ann Surg Oncol. 2007;14:1381-1396.
16. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235:728-739.
17. Seror O, N'Kontchou G, Ibraheem M, Ajavon Y, Barrucand C, Ganne N, et al. Large >(or = 5.0 cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes - initial experience in 26 patients. Radiology. 2008;248:288-296.
18. Hänsler J, Frieser M, Tietz V, Uhlke D, Wissniowski T, Bernatik T, et al. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes. J Vasc Interv Radiol. 2007;18:405-410.
19. de Baere T, Deschamps F, Briggs P, Dromain C, Boige V, Hechelhammer L, et al. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. Radiology. 2008;248:1056-1066.
20. Shen P, Fleming S, Westcott C, Challa V. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver. J Surg Oncol. 2003;83:36-41.
21. Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, et al. Extension of RF radiofrequency ablation of the liver of the liver by TAE with iodized oil and gelatin sponge: results in a pig model. JVIR. 2005;16:849-856.
22. Guang C, Kawai N, Sato M, Takasaka I, Minamiguchi H, Sahara S, et al. Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model. Jpn J Radiol. 2011;29:649-655.
23. Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Interv Radiol. 1993;16:348-354.
24. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology. 2009;252:905-913.